Ontology highlight
ABSTRACT: Background
Tuberculosis (TB-)-preventive therapy (TPT) among pregnant women reduces risk of TB in mothers and infants, but timing of initiation should consider potential adverse effects. We propose an analytical approach to evaluate the risk-benefit of interventions.Methods
A novel outcome measure that prioritizes maternal and infant events was developed with a 2-stage Delphi survey, where a panel of stakeholders assigned scores from 0 (best) to 100 (worst) based on perceived desirability. Using data from TB APPRISE, a trial among pregnant women living with human immunodeficiency virus (WLWH) that randomized the timing of initiation of isoniazid, antepartum versus postpartum, was evaluated.Results
The composite outcome scoring/ranking system categorized mother-infan
SUBMITTER: Montepiedra G
PROVIDER: S-EPMC8326545 | biostudies-literature | 2021 Aug
REPOSITORIES: biostudies-literature